Literature DB >> 30059458

Hidden burden of venous thromboembolism after trauma: A national analysis.

Rishi Rattan1, Joshua Parreco, Sarah A Eidelson, Joann Gold, Arjuna Dharmaraja, Tanya L Zakrison, D Dante Yeh, Enrique Ginzburg, Nicholas Namias.   

Abstract

BACKGROUND: Trauma patients are at increased risk for venous thromboembolism (VTE). One in four trauma readmissions occur at a different hospital. There are no national studies measuring readmissions to different hospitals with VTE after trauma. Thus, the true national burden in trauma patients readmitted with VTE is unknown and can provide a benchmark to improve quality of care.
METHODS: The Nationwide Readmission Database (2010-2014) was queried for patients ≥18 years non-electively admitted for trauma. Patients with VTE or inferior vena cava filter placement on index admission were excluded. Outcomes included 30-day and 1-year readmission to both index and different hospitals with a new diagnosis of VTE. Multivariable logistic regression identified risk factors. Results were weighted for national estimates.
RESULTS: Of the 5,151,617 patients admitted for trauma, 1.2% (n = 61,800) were readmitted within 1 year with VTE. Of those, 29.6% (n = 18,296) were readmitted to a different hospital. Risk factors for readmission to a different hospital included index admission to a for-profit hospital (OR 1.33 [1.27-1.40], p < 0.001), skull fracture (OR 1.20 [1.08-1.35], p < 0.001), Medicaid (OR 1.16 [1.06-1.26], p < 0.001), hospitalization >7 days (OR 1.12 [1.07-1.18], p < 0.001), and the lowest quartile of median household income for patient ZIP code (OR 1.13 [1.07-1.19], p < 0.01). The yearly cost of 1-year readmission for VTE was $256.9 million, with $90.4 million (35.2%) as a result of different hospital readmission.
CONCLUSIONS: Previously unreported, over one in three patients readmitted with VTE a year after hospitalization for trauma, accounting for over a third of the cost, present to another hospital and are not captured by current metrics. Risk factors are unique. This has significant implications for benchmarking, outcomes, prevention, and policy. LEVEL OF EVIDENCE: Epidemiological study, level II.

Entities:  

Mesh:

Year:  2018        PMID: 30059458     DOI: 10.1097/TA.0000000000002039

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  4 in total

Review 1.  Trauma-induced pulmonary thromboembolism: What's update?

Authors:  Yu-Hong Mi; Ming-Ying Xu
Journal:  Chin J Traumatol       Date:  2021-08-05

2.  Association Between Monocyte Count and Preoperative Deep Venous Thrombosis in Older Patients with hip Fracture: A Retrospective Study.

Authors:  Zhicong Wang; Qing Zhou; Hailong Liu; Jianjun Zhang; Zhonglun Zhu; Jijun Wu; Xue Chen; Yuehong Liu
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

3.  Updated guidelines to reduce venous thromboembolism in trauma patients: A Western Trauma Association critical decisions algorithm.

Authors:  Eric J Ley; Carlos V R Brown; Ernest E Moore; Jack A Sava; Kimberly Peck; David J Ciesla; Jason L Sperry; Anne G Rizzo; Nelson G Rosen; Karen J Brasel; Rosemary Kozar; Kenji Inaba; Matthew J Martin
Journal:  J Trauma Acute Care Surg       Date:  2020-11       Impact factor: 3.313

4.  Sufficient Thrombin Generation Despite 95% Hemodilution: An In Vitro Experimental Study.

Authors:  Johannes Gratz; Christoph J Schlimp; Markus Honickel; Nadine Hochhausen; Herbert Schöchl; Oliver Grottke
Journal:  J Clin Med       Date:  2020-11-25       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.